Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
NCT06580002
Adnexal Diseases, Blood Protein Disorders
Orange, California, United States
View Trial DetailsNCT Number: NCT07129317
The Johns Hopkins Pediatric Radiation Oncology Program is creating a registry that will capture the full 3D radiation dosimetry delivered to its pediatric patients to manage the quality of care provided, as well as to examine the long-term outcomes and toxicity of each patient. The registry will capture baseline clinical data, disease, toxicity, and quality of life outcomes. The goal is to include all pediatric patients undergoing proton therapy and photon therapy to enable future comparisons of treatment outcomes.
Interested in participating?
Request Info0 year–26 year
All sexes
Observational
Sibley Memorial Hospital, Washington D.C., District of Columbia, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Approximately 10 years
Measured from date of diagnosis until death, obtained from medical record notes
Time frame: Approximately 10 years
The number of patients that experience adverse events, obtained from medical record notes
Contact information is provided by the study sponsor or research team.
Betsy Sawdy, MSN
CONTACT
Ethan Arnone, BS
CONTACT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06580002
Adnexal Diseases, Blood Protein Disorders
Orange, California, United States
View Trial DetailsNCT05890781
Adenocarcinoma, Brain Diseases
Villejuif, France
View Trial DetailsNCT05366881
Adnexal Diseases, Bladder Cancer
Duarte, California, United States
View Trial DetailsNCT01875601
Brain Diseases, Brain Neoplasms
Bethesda, Maryland, United States
View Trial Details